Assignee
HALIA THERAPEUTICS INC
US·6 granted patents·10 pending applications·15 citations·filing 2021–2025
Top patents by PatentIndex Score
16 records- 0195US11161852B1Inhibitors of NEK7 kinaseHALIA THERAPEUTICS INC·Filed 2021·Granted Nov 2, 2021·8 cites·27 claims
- 0294US11578061B2Inhibitors of LRRK2 kinaseHALIA THERAPEUTICS INC·Filed 2022·Granted Feb 14, 2023·3 cites·27 claims
- 0393US11866423B2Inhibitors of LRRK2 kinaseHALIA THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·2 cites·26 claims
- 0491US11713321B2Inhibitors of NEK7 kinaseHALIA THERAPEUTICS INC·Filed 2021·Granted Aug 1, 2023·2 cites·22 claims
- 0586US2026055087A1Inhibitors of lrrk2 kinaseHALIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0683US12428404B2Inhibitors of LRRK2 kinaseHALIA THERAPEUTICS INC·Filed 2023·Granted Sep 30, 2025·0 cites·22 claims
- 0778US12091413B2Inhibitors of NEK7 kinaseHALIA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·20 claims
- 0863US2024158394A1Nek7 inhibitorsHALIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0960US2025019378A1Pyrrole[2,3-b]pyridine derivatives as tyro3 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1059US2024425499A1Tyro3 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1157US2024382488A1Nek7 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1257US2025177382A1Nek7 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2024317758A1Nek7 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1456US2024400551A1Nek7 inhibitorsHALIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1554US2023210853A1Targeted nek7 inhibition for modulation of the nlrp3 inflammasomeHALIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1653US2023203045A1Inhibitors of nek7 kinaseHALIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →